You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / MARKSANS PHARMA LTD

MARKSANS PHARMA LTD Analysis

Returns | 1W : -0.5% , 1M : -4.2%,1Y : 190%
BOM : 524404     NSE : MARKSANS    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Jan 22,2021
Price(EOD): Rs. 56.50
This is the End-of-Day (EOD) Stock Price updated daily by 10 pm IST.
MarketCap: Rs. 2,312.55 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
MARKSANS PHARMA LTD -0.5% -4.2% 190%
SUN PHARMACEUTICAL INDUSTRIES LTD -1.1% 0.1% 30.6%
DR REDDYS LABORATORIES LTD -0.4% -3.6% 65.1%
DIVIS LABORATORIES LTD -0.6% -3.9% 94.4%
CIPLA LTD 0.8% -2% 72.3%
BIOCON LTD -12.3% -18.6% 51%
AUROBINDO PHARMA LTD 0.8% 3.8% 81.4%
LUPIN LTD 1.6% 12.1% 44.7%
TORRENT PHARMACEUTICALS LTD 2.1% -3.9% 37%

FUNDAMENTAL ANALYSIS OF MARKSANS PHARMA LTD

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than MARKSANS PHARMA LTDPremium

As on 22-Jan-2021, the Fundamentals of MARKSANS PHARMA LTD are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of MARKSANS PHARMA LTD. Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!


VALUATION OF MARKSANS PHARMA LTD

 
Valuation Score
RatioValue
P/E
P/B
P/S
19.76
P/E Calculated based on EPS of 2.86
[ Mar2020 - Consolidated Results ]

3.64
P/B Calculated based on Book Value of 15.54
[ Mar2020 - Consolidated Results ]

1.91
P/S Calculated based on Revenues of 1210.55 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than MARKSANS PHARMA LTDPremium

As on 22-Jan-2021, MARKSANS PHARMA LTD is Fairly Valued and investors can wait for the buying opportunity once it becomes under valued!


INTRINSIC VALUE OF MARKSANS PHARMA LTD

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-18%
-15%
3%

As on 22-Jan-2021, the Intrinsic Value of MARKSANS PHARMA LTD is Rs. 66.72 determined based on Median of the 3 historical models.
Fair Value based on Median EV / EBIDTA Model : Rs. 68.90
Fair Value based on Median EV / Sales Model : Rs. 66.72
Fair Value based on Median Price / Sales Model : Rs. 54.86
Median Fair Value of MARKSANS PHARMA LTD : Rs. 66.72

As on 22-Jan-2021, MARKSANS PHARMA LTD is trading at a Discount of -15% based on the Median Intrinsic Value!


SHARE PRICE MOMENTUM OF MARKSANS PHARMA LTD

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0
0.17
0.16
0.11
0.03
0.18
0.25
0.15
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
0 %
As on : Sep2020

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated 1 Qtr Growth 4 Qtr Growth
Revenue
Op Profit
EBIDT
Net Income
7.65%
23.68%
7.32%
2.77%
39.03%
109.48%
95.77%
95.36%
QtrlyTrend
8
Latest Qtr: Sep2020




Open Demat Account & Start Investing
    Affiliate Links

Disclosure

The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].
All Stocks : A - Z
ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z